Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ShareHope Medicine Co's total equity for the quarter that ended in Mar. 2026 was NT$3,802 Mil.
This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.
ShareHope Medicine Co Total Equity Historical Data
* Premium members only.
The historical data trend for ShareHope Medicine Co's Total Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ShareHope Medicine Co (ROCO:8403) has a Total Equity of NT$3,802 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for ShareHope Medicine Co and its competitors.
Is ShareHope Medicine Co's Total Equity too high?
ShareHope Medicine Co's current Total Equity is NT$3,802 Mil. Overall, ShareHope Medicine Co has a GF Score™ of 70/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does ShareHope Medicine Co's Total Equity compare to MCK and COR?
ShareHope Medicine Co's Total Equity of NT$3,802 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Distribution company?
A good Total Equity depends on the Medical Distribution industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for ShareHope Medicine Co and its competitors. ShareHope Medicine Co's current Total Equity is NT$3,802 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ShareHope Medicine Co stock overvalued right now?
Based on GuruFocus' analysis, ShareHope Medicine Co (ROCO:8403) is currently considered Possible Value Trap. The stock's GF Value™ is NT$29.89, compared to a current price of NT$18.95 — trading 36.6% below its estimated fair value. The current Total Equity is NT$3,802 Mil. ShareHope Medicine Co's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For ShareHope Medicine Co (ROCO:8403), the current Total Equity is NT$3,802 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ShareHope Medicine Co (ROCO:8403) Overvalued in 2026?
Based on GuruFocus' analysis, ShareHope Medicine Co stock appears to be undervalued.
The current stock price of NT$18.95 is trading 36.6% below its estimated GF Value™ of NT$29.89.
GuruFocus considers ShareHope Medicine Co to be Possible Value Trap.
Key valuation signals for ROCO:8403:
Total Equity: NT$3,802 Mil
GF Value™: NT$29.89 vs. price of NT$18.95 (36.6% below fair value)
No single metric tells the full story. See the ROCO:8403 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ShareHope Medicine Co Ltd is engaged in wholesale and retail sales of medicines and hygiene materials, leasing of assets for medical institutions to undertake related medical services, and physical examinations for Taiwanese people and foreign labors, on-site medical support services, hemodialysis business management, ophthalmic medical management, clothing-related management services, manufacturing, processing and sales of various non-woven fabrics and management consulting for chain pharmacies in collaboration with medical institutions.
70GF Score
Get the complete analysis for ROCO:8403
Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:8403 has been successfully added to your 
